ArticleEmerging infectious diseases2016
New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan.
Article in Emerging infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Antimicrobial resistance of Neisseria gonorrhoeae in Latin American countries: a systematic review.The Journal of antimicrobial chemotherapy · 2023Pooled it
- Pooled it
- Rapid detection of ceftriaxone-resistantMicrobiology spectrum · 2026Article
- Clonal Expansion ofInfection and drug resistance · 2026Article
- Cefotaxime-Resistant Neisseria meningitidis Sequence Type 4821 Causing Fulminant Meningitis.Emerging infectious diseases · 2025Article
- Bioactive Compounds Isolated from a Marine Sponge Selectively InhibitAntibiotics (Basel, Switzerland) · 2024Article
- Multigeographic clinical assessment of a molecular diagnostic assay for detection of key codons to predict decreased susceptibility or resistance to cephalosporins inAntimicrobial agents and chemotherapy · 2024Article
- Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015-24: an observational analysis.The Journal of antimicrobial chemotherapy · 2024Observational
- Molecular epidemiological and antimicrobial-resistant mechanisms analysis of prolongedJAC-antimicrobial resistance · 2024Article
- 2023 Korean Association of Urogenital Tract Infection and Inflammation guidelines for gonococcal infection.Investigative and clinical urology · 2024Review
- Identification of ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone and isolates harboring a novel mosaic penA gene in Chengdu in 2019-2020.Annals of clinical microbiology and antimicrobials · 2023Article
- Review
- Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.BMC infectious diseases · 2021Article
- Typing ofAntimicrobial agents and chemotherapy · 2021Article
- Impact of the gonococcal FC428Emerging microbes & infections · 2020Article
- A Loop-Mediated Isothermal Amplification Assay Targeting Neisseria gonorrhoeaeAntimicrobial agents and chemotherapy · 2019Article
- HighAntimicrobial agents and chemotherapy · 2019Article
- Review
- In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?The Journal of antimicrobial chemotherapy · 2019Article
- Typing and antimicrobial susceptibility of 134 Neisseria gonorrhoeae strains from Southern Spain.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.